Related Experiment Videos

Left ventricular and carotid structure in untreated, uncomplicated essential hypertension: results from the

C Cuspidi1, G Mancia, E Ambrosioni

  • 1Istituto di Medicina Cardiovascolare, Università di Milano, Milano, Italy. dhipertensione@libero.it

Insights

Hypertension significantly impacts heart and artery structure in untreated patients. Left ventricular hypertrophy (LVH) and carotid artery thickening are common and linked, increasing with age and higher blood pressure.

Area of Science:

  • Cardiology
  • Vascular Biology
  • Hypertension Research

Background:

  • Essential hypertension affects cardiovascular and vascular structures.
  • The relationship between left ventricular hypertrophy (LVH) and vascular changes in untreated hypertension requires further investigation.

Purpose of the Study:

  • To determine the prevalence of structural abnormalities in the left ventricle (LV) and carotid arteries.
  • To identify determinants of LVH and carotid structural changes in untreated essential hypertensive patients.

Main Methods:

  • A multicentre prospective study involving 1142 untreated essential hypertensive patients.
  • Ultrasound examinations of the heart and carotid arteries were performed.
  • LVH and carotid structural changes were defined by specific criteria (LV mass index, plaque presence, intima-media thickness).

Main Results:

  • Prevalence of LVH was 26.8%, with eccentric hypertrophy being more common than concentric.
  • Carotid plaques or thickening were present in 27.4% of patients.
  • A significant association was found between carotid wall thickening and LVH, particularly concentric LVH.

Conclusions:

  • Altered LV structure/geometry and carotid structural changes are prevalent in untreated essential hypertension.
  • LVH and carotid thickening are significantly associated and influenced by age, systolic blood pressure, and metabolic factors.

Related Concept Videos

Hypertension III: Clinical Manifestations and Diagnostic Studies01:30

Hypertension III: Clinical Manifestations and Diagnostic Studies

Hypertension is asymptomatic and also referred to as the "silent killer" until it progresses to a severe stage or causes target organ disease. Patients may experience symptoms stemming from the strain on blood vessels and tissues in various organs or the heart's increased workload.Physical exams might show no abnormalities other than high blood pressure. Signs of vascular damage, when present, correspond to the organs supplied by the affected vessels, leading to target organ damage. For...
Hypertension II: Pathophysiology01:29

Hypertension II: Pathophysiology

Hypertension is a chronic condition in which the blood's force against artery walls is excessively high, posing risks such as heart disease. The condition's underlying mechanisms involve complex interactions among the cardiovascular, kidney, and autonomic nervous systems.Renin-Angiotensin-Aldosterone System (RAAS): This system significantly influences blood pressure regulation. When blood pressure decreases, the kidneys secrete renin. This enzyme transforms angiotensinogen, a plasma protein,...
Hypertension and Regulation of Blood Pressure01:18

Hypertension and Regulation of Blood Pressure

Hypertension, the most common cardiovascular disease, is diagnosed through repeated measurements of elevated blood pressure. Its risks, including damage to the kidney, heart, and brain, are directly proportional to blood pressure levels. Starting from 115/75 mm Hg, the risk of cardiovascular disease doubles with each increment of 20/10 mm Hg. The diagnosis relies on blood pressure measurements, not on patient symptoms, as hypertension is often asymptomatic until end-organ damage is imminent or...
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...